substance p has been researched along with Obesity in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (16.00) | 18.7374 |
1990's | 3 (12.00) | 18.2507 |
2000's | 6 (24.00) | 29.6817 |
2010's | 12 (48.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antonioli, L; Benvenuti, L; Bernardini, N; Blandizzi, C; Carpi, S; Colucci, R; Duranti, E; Fornai, M; Gentile, D; Ippolito, C; Németh, ZH; Nieri, P; Pellegrini, C; Pistelli, L; Segnani, C; Tirotta, E; Virdis, A | 1 |
Balemba, O; Gericke, M; Kappmeyer, AJ; Schmalz, JT; Stenkamp-Strahm, CM | 1 |
Balemba, OB; Gericke, M; Horton, S; Kappmeyer, AJ; Nyavor, YE; Stenkamp-Strahm, CM | 1 |
Karagiannides, I; Pothoulakis, C | 1 |
Bełtowski, J; Jamroz-Wiśniewska, A; Wójcicka, G; Wojtak, A | 1 |
Cureton, E; Curran, B; Dozier, K; Kwan, RO; Sadjadi, J; Victorino, GP | 1 |
Fu, J; Li, G; Liu, B; Liu, L; Liu, P; Liu, X; Wu, B | 1 |
Bakirtzi, K; Bowe, C; Bugni, JM; Gerard, NP; Karagiannides, I; Kirkland, JL; Kokkotou, E; Leeman, SE; Lu, B; Nayeb-Hashemi, H; Nuño, M; Pirtskhalava, T; Pothoulakis, C; Stavrakis, D | 1 |
Bloom, SR; Gardiner, JV; Patterson, M | 1 |
Ai, J; Liu, J; Sun, L; Wang, N; Wei, R; Xie, F; Xu, Y; Yang, C; Zhang, R | 1 |
Almeida, J; Beltrão, M; Costa, R; Delgado, L; Guardão, L; Guimarães, JT; Moreira, A; Palmares, C; Pirraco, A; Ramalho, R; Soares, R; Sokhatska, O | 2 |
Åberg, M; Brorson, H; Ekman, R; Fagher, B; Hansson, E; Manjer, J; Svensson, H | 1 |
Barbara, G; Busacchi, P; Corinaldesi, R; De Giorgio, R; Guerrini, S; Oliverio, C; Paradisi, R; Perri, T; Santini, D; Stanghellini, V | 1 |
Dhanasekaran, S; Mensah-Brown, E; Morrison, JF; Shaffiullah, M; Sheen, R; Shehab, S | 1 |
Cicha, MZ; Kopp, UC; Yorek, MA | 1 |
Desouza, CA; Greiner, JJ; Stauffer, BL; Van Guilder, GP | 1 |
Bowe, C; Carvalho, E; Espinoza, D; Karagiannides, I; Kokkotou, E; Pothoulakis, C; Torres, D; Tseng, YH | 1 |
Felder, M | 1 |
Lechner, O; Panerai, AE; Sacerdote, P; Sidman, C; Wick, G | 1 |
Bloom, SR | 1 |
Ball, JM; Bloom, SR; Cardoso, HM; Ghatei, MA; Lee, YC; Stock, MJ; Williams, G | 1 |
Bloom, SR; Cardoso, HM; Domin, J; Ghatei, MA; Russell, JC; Williams, G | 1 |
MacLean, DB | 1 |
Bailey, CJ; Conlon, JM; Deacon, CF; Flatt, PR; Shaw, C | 1 |
3 review(s) available for substance p and Obesity
Article | Year |
---|---|
Substance P, obesity, and gut inflammation.
Topics: Adipose Tissue; Developed Countries; Gastrointestinal Diseases; Humans; Inflammation; Inflammatory Bowel Diseases; Obesity; Substance P | 2009 |
Ghrelin and appetite control in humans--potential application in the treatment of obesity.
Topics: Acyltransferases; Adipose Tissue; Adiposity; Animals; Antibodies, Neutralizing; Appetite; Appetite Regulation; Eating; Fasting; Ghrelin; Humans; Hunger; Mice; Obesity; Peptide Hormones; Peptide YY; Peptides; Rats; Receptors, Ghrelin; Satiety Response; Substance P; Weight Gain | 2011 |
[The fibrositis syndrome (author's transl)].
Topics: Adult; Behavior Therapy; Chlorpromazine; Edema; Endorphins; Female; Fibromyalgia; Humans; Male; Middle Aged; Neurotic Disorders; Obesity; Pain; Pain Management; Sleep Wake Disorders; Substance P; Syndrome; Tryptophan | 1980 |
1 trial(s) available for substance p and Obesity
Article | Year |
---|---|
Impaired endothelium-dependent vasodilation in overweight and obese adult humans is not limited to muscarinic receptor agonists.
Topics: Acetylcholine; Adult; Aged; Body Mass Index; Bradykinin; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Infusions, Intravenous; Isoproterenol; Male; Methacholine Chloride; Middle Aged; Muscarinic Agonists; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Obesity; Regional Blood Flow; Signal Transduction; Substance P; Vasodilation; Vasodilator Agents | 2008 |
21 other study(ies) available for substance p and Obesity
Article | Year |
---|---|
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity.
Topics: Adipose Tissue; Animals; Apigenin; Body Weight; Colon; Diet, High-Fat; Eosinophils; Flavonoids; Gene Expression Regulation, Enzymologic; Inflammation; Interleukin-1beta; Interleukin-6; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; MicroRNAs; Motor Activity; Muscle, Smooth; Nitric Oxide Synthase Type II; Obesity; Organ Size; Substance P | 2018 |
High-fat diet ingestion correlates with neuropathy in the duodenum myenteric plexus of obese mice with symptoms of type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Diet, High-Fat; Duodenum; Mice; Mice, Inbred C57BL; Mice, Obese; Myenteric Plexus; Neurons; Nitric Oxide Synthase; Obesity; Substance P; Vasoactive Intestinal Peptide | 2013 |
Prolonged high fat diet ingestion, obesity, and type 2 diabetes symptoms correlate with phenotypic plasticity in myenteric neurons and nerve damage in the mouse duodenum.
Topics: Animals; Apoptosis; Diabetes Mellitus, Type 2; Diet, High-Fat; Duodenum; Enteric Nervous System; Insulin Resistance; Mice; Mice, Inbred C57BL; Myenteric Plexus; Neurodegenerative Diseases; Neurons; Nitric Oxide Synthase; Obesity; Substance P | 2015 |
Chronic hyperleptinemia induces resistance to acute natriuretic and NO-mimetic effects of leptin.
Topics: Androstadienes; Animals; Aorta; Blood Pressure; Cyclic GMP; Humans; Insulin; Kidney Medulla; Leptin; Male; Natriuresis; Nitric Oxide; Obesity; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Ribonucleosides; Sodium; Sodium-Potassium-Exchanging ATPase; Substance P; Wortmannin | 2010 |
Ghrelin decreases microvascular leak during inflammation.
Topics: Animals; Capillary Permeability; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Ghrelin; Lipopolysaccharides; Mesentery; NF-kappa B; Obesity; Rats; Rats, Sprague-Dawley; Receptors, Ghrelin; Sesquiterpenes; Signal Transduction; Substance P; Systemic Inflammatory Response Syndrome; Venules; Wounds and Injuries | 2010 |
Substance P is associated with the development of obesity, chronic inflammation and type 2 diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; C-Reactive Protein; Cholesterol; Diabetes Mellitus, Type 2; Female; Humans; Insulin; Interleukin-6; Male; Middle Aged; Obesity; Substance P; Triglycerides; Uric Acid | 2011 |
Substance P (SP)-neurokinin-1 receptor (NK-1R) alters adipose tissue responses to high-fat diet and insulin action.
Topics: Adipose Tissue; Animals; Dietary Fats; Female; Glucose; Humans; Insulin; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Rats; Rats, Inbred F344; Receptors, Neurokinin-1; Signal Transduction; Substance P; Weight Gain | 2011 |
Long-term neuropeptide Y administration in the periphery induces abnormal baroreflex sensitivity and obesity in rats.
Topics: Animals; Baroreflex; Blood Pressure; Cholesterol; Heart Rate; Lipoproteins, LDL; Male; Neuropeptide Y; Nitroprusside; Obesity; Rats; Rats, Wistar; Receptors, AMPA; Receptors, GABA-A; Substance P; Triglycerides; Weight Gain | 2012 |
Neurogenic inflammation in allergen-challenged obese mice: A missing link in the obesity-asthma association?
Topics: Allergens; Animals; Asthma; Blood Glucose; Bronchoalveolar Lavage Fluid; Cell Count; Diet, High-Fat; Immunoglobulin E; Insulin; Lung; Mice; Mice, Inbred BALB C; Mice, Obese; Neurogenic Inflammation; Obesity; Ovalbumin; Substance P; Tachykinins | 2012 |
Neuropeptide levels in Dercum's disease (adiposis dolorosa).
Topics: Adiposis Dolorosa; Humans; Neuropeptide Y; Neuropeptides; Obesity; Substance P; Vasoactive Intestinal Peptide | 2012 |
Substance P antagonist improves both obesity and asthma in a mouse model.
Topics: Allergens; Animals; Asthma; Biomarkers; Bronchial Hyperreactivity; Bronchitis; Disease Models, Animal; Mice; Neurokinin-1 Receptor Antagonists; Obesity; Substance P | 2013 |
Abnormalities of somatic peptide-containing nerves supplying the pelvic floor of women with genitourinary prolapse and stress urinary incontinence.
Topics: Aged; Biomarkers; Biopsy; Birth Weight; Connective Tissue; Denervation; Female; Humans; Middle Aged; Models, Neurological; Muscle, Skeletal; Nerve Tissue Proteins; Neurons; Neuropeptide Y; Neuropeptides; Obesity; Parity; Pelvic Floor; Peripheral Nervous System Diseases; Phosphopyruvate Hydratase; Postmenopause; Rectum; S100 Proteins; Substance P; Urethra; Urinary Incontinence, Stress; Uterine Prolapse; Vasoactive Intestinal Peptide | 2004 |
Sensory and autonomic nerve changes in the monosodium glutamate-treated rat: a model of type II diabetes.
Topics: Aging; Animals; Autonomic Nervous System; Blood Glucose; Body Weight; Calcitonin Gene-Related Peptide; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Glucose Intolerance; Glucose Tolerance Test; Hot Temperature; Immunohistochemistry; Insulin; Insulin-Secreting Cells; Neurons, Afferent; Obesity; Organ Size; Pain Measurement; Physical Stimulation; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Neurokinin-1; Sodium Glutamate; Substance P | 2008 |
Impaired responsiveness of renal sensory nerves in streptozotocin-treated rats and obese Zucker diabetic fatty rats: role of angiotensin.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensins; Animals; Baroreflex; Capsaicin; Diabetes Mellitus, Experimental; Dinoprostone; Kidney; Losartan; Male; Mechanoreceptors; Neurons, Afferent; Obesity; Rats; Rats, Sprague-Dawley; Rats, Zucker; Substance P | 2008 |
Substance P as a novel anti-obesity target.
Topics: Adiposity; Animals; Anti-Obesity Agents; Appetite Regulation; Blood Glucose; Body Weight; Bridged Bicyclo Compounds, Heterocyclic; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Energy Metabolism; Feeding Behavior; Injections, Intraperitoneal; Insulin; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Neurokinin-1 Receptor Antagonists; Obesity; Receptors, Neurokinin-1; Substance P; Time Factors | 2008 |
Hypothalamic beta-endorphin concentrations are decreased in animals models of autoimmune disease.
Topics: Animals; Autoimmune Diseases; beta-Endorphin; Chickens; Female; Hypothalamus; Male; Mice; Mice, Inbred MRL lpr; Neuroimmunomodulation; Obesity; Proteinuria; Substance P; Thyroiditis, Autoimmune | 1999 |
Hormonal peptides of the gastrointestinal tract.
Topics: Brain; Celiac Disease; Digestive System Physiological Phenomena; Gastric Inhibitory Polypeptide; Gastrins; Gastrointestinal Hormones; Glucagon-Like Peptides; Humans; Obesity; Pancreas; Pancreatic Neoplasms; Pancreatic Polypeptide; Secretin; Somatostatin; Substance P | 1979 |
Hypothalamic regulatory peptides in obese and lean Zucker rats.
Topics: Animals; Bombesin; Calcitonin Gene-Related Peptide; Food Deprivation; Galanin; Hypothalamus; Hypothalamus, Middle; Neurokinin B; Neuropeptide Y; Neuropeptides; Neurotensin; Obesity; Peptides; Radioimmunoassay; Rats; Rats, Zucker; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 1991 |
Hypothalamic regulatory peptide disturbances in the spontaneously obese JCR: LA-corpulent rat.
Topics: Animals; Diet, Reducing; Female; Galanin; Hypothalamus; Insulin; Neuropeptide Y; Neuropeptides; Neurotensin; Obesity; Organ Specificity; Peptides; Rats; Rats, Mutant Strains; Reference Values; Somatostatin; Substance P; Weight Loss | 1990 |
Abrogation of peripheral cholecystokinin-satiety in the capsaicin treated rat.
Topics: Aging; Animals; Animals, Newborn; Biological Transport; Capsaicin; Cholecystokinin; Fasting; Feeding Behavior; Insulin; Obesity; Rats; Rats, Inbred Strains; Satiation; Satiety Response; Somatostatin; Substance P; Vagus Nerve; Ventromedial Hypothalamic Nucleus | 1985 |
Substance P, neurokinin A, vasoactive intestinal polypeptide and gastrin releasing peptide in the intestine and pancreas of spontaneously obese-diabetic mice.
Topics: Animals; Diabetes Mellitus; Gastrin-Releasing Peptide; Insulin; Insulin Secretion; Intestines; Mice; Mice, Inbred C57BL; Mice, Obese; Mutation; Neurokinin A; Neuropeptides; Obesity; Pancreas; Peptides; Substance P; Vasoactive Intestinal Peptide | 1986 |